P3.12-03 Targeting DLL3 With AMG 757, a BiTE® Antibody Construct, and AMG 119, a CAR-T, for the Treatment of SCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1826
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

OA13.02 Two Novel Immunotherapy Agents Targeting DLL3 in SCLC: Trials in Progress of AMG 757 and AMG 119

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.12-02 Dynamics of DLL3 and ASCL1 Expression in SCLC Over Disease Course

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Bootstrap AMG for Spectral Clustering

Computational and Mathematical Methods
2019English

P3.12-01 Targeting Mitochondrial Metabolism as a Selective Therapeutic Approach in Small Cell Lung Cancer (SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Dual Targeting Car-T Cell Approach for the Treatment of B Cell Malignancies

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

An AMG Preconditioner for Solving the Navier-Stokes Equations With a Moving Mesh Finite Element Method

East Asian Journal on Applied Mathematics
Applied Mathematics
2016English

Targeting Glioblastoma With CAR T Cells

Cancer Discovery
Oncology
2017English

AMG Volume 33 Issue 2 Cover and Front Matter

Acta geneticae medicae et gemellologiae: twin research
1984English

AMG Volume 37 Issue 2 Cover and Back Matter

Acta geneticae medicae et gemellologiae: twin research
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy